Quarterly report pursuant to Section 13 or 15(d)

NOTE 6: MARKETABLE SECURITIES

v3.19.3
NOTE 6: MARKETABLE SECURITIES
9 Months Ended
Sep. 30, 2019
Notes  
NOTE 6: MARKETABLE SECURITIES

NOTE 6: MARKETABLE SECURITIES

 

The Company utilizes FAS 115 “Accounting for Certain Investments in Debt and Equity Securities”. The Company received marketable securities, 10,300,000 fully paid ordinary unrestricted shares in Impression Healthcare Limited (Australian Company), traded on Australian Security Exchange by the code IHL as part of the agreement and letter of intent (LOI). The Company categorize these securities as trading securities and report them at fair value, with realized and unrealized gains and losses included in earnings. The Company recorded securities at FMV at the price of A$0.02 per share and exchange rate of $0.74 AUD/USD valued $150,000. As of September 30, 2019, the Company received another 2,000,000 shares and sold 5,260,000 shares. On September 30, 2019 the stock price was A$ 0.085 per share as quoted on www.asx.com.au and exchange rate of $0.676 AUD/USD as quoted on www.oanda.com and had FMV $404,518. The change to the FMV in marketable securities for the period resulted in realized and unrealized gain of $190,460, $190,460, $135,320, and $273,720 for three and nine months ended September 30, 2019 respectively. There is a receivable of $89,568 due from the brokerage as a result of the sale of shares.